Healthcare Equity Research
No mentions found
This entity hasn't been tracked yet, or Iris is still building its knowledge base.
Related Articles from SNS
‘Buying stuff like it’s going out of fashion’: Biotech M&A on track for best year since pre-Covid
Global biopharma M&A is experiencing a sharp uptick, putting the sector on track for its strongest year since the pre-pandemic peak seven years ago. Driven by looming patent cliffs, newly buoyant public markets, and Big Pharma's race to beef up their pipelines, dealmaking so far in 2026 amounted to $106 billion over 201 deals, according to PitchBook data. If the current pace of biopharma M&A holds up for the rest of the year, the industry could be on track to notch more than $250 billion in...
Investors bet humanoid robots will transform industry and homes over the next decade
Softbank CEO Masayoshi Son told CNBC this week that physical AI and robotics were where he saw the next trillion-dollar company emerging from. Humanoid robots, designed to mimic human movement and capabilities, have been hitting headlines in recent years, from their use as baggage handlers at Japanese airports to Tesla's big bet on its Optimus humanoid. Market watchers have predicted that the machines will change the world over the next decade and forecast that the industry will grow...